CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 1,000 shares at $6.50 ($6,500)
- 4 Open-market buy Director bought 2,000 shares at $6.27 ($12,540)
- 4 Open-market buy Director bought 2,944 shares at $6.31 ($18,577)
- 4 Open-market buy Director bought 3,000 shares at $6.25 ($18,750)
- 4 Open-market buy Director bought 1,000 shares at $6.15 ($6,150)
- 4 Open-market buy Director bought 2,000 shares at $6.09 ($12,180)
- 4 Open-market buy Director bought 3,000 shares at $6.12 ($18,360)
- 4 Option exercise Director acquired 114,552 shares (option exercise)
- 4 Open-market buy Director bought 500 shares at $5.83 ($2,915)
- 4 Open-market buy Director bought 2,500 shares at $4.92 ($12,300)
- 4 Open-market buy Director bought 2,100 shares at $4.82 ($10,122)
- 4 Open-market buy Director bought 5,000 shares at $4.75 ($23,750)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 33 · 659 filings